At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 148 enrolled
Drug / intervention
Ketorolacdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial
In Brief
A Phase 3 clinical trial evaluating Ketorolac for Post-operative Pain and 2 related conditions. Completed, enrolled 148 participants across 1 site.
Detailed Summary
To evaluate the efficacy of increased ketorolac in reducing opioid use after cesarean section.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20192020202120222023202420252026
First PostedSep 2018
Enrollment StartMay 2019
Primary CompletionJan 2022
Study CompletionJun 2022
TodayJul 2026
First PostedSep 19, 2018
Enrollment StartMay 30, 2019
Primary CompletionJan 31, 2022
Study CompletionJun 30, 2022
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 7.8 years ago
Interventions
Ketorolacdrug
The intervention is a protocol of scheduled IV Ketorolac administered postoperatively.